Motor neuron disease is a major group of inherited or spontaneous disorders that are associated with muscular atrophy. Recently, muscle preparations from the genetic wobbler mouse model of primary motor neuronopathy have been analyzed by mass spectrometry-based proteomics. e progressive degeneration of individual motor neurons was shown to cause complex alterations in the concentration or isoform expression pattern of muscle proteins involved in the excitation-contraction-relaxation cycle, the cytoskeleton, ion handling, cellular signaling, the stress response and energy metabolism. In this article, we compare the panel of potential new muscle-associated biomarkers that have been obtained by two di erent, but complementary, bioanalytical approaches, i.e. label-free mass spectrometric analysis versus uorescence twodimensional di erence-in gel electrophoresis. e complex disease-associated changes in the muscle proteome are considerably di erent to the more unilateral skeletal muscle transitions observed in experimentally denervated bers or disuse-related muscular atrophy. e apparent subtype-speci c vulnerability of neuromuscular synapses and compensatory mechanisms of ber type shi ing in motor neuron disease is discussed, and contrasted to other forms of muscular atrophy.
Introduction
Mass spectrometry-based proteomics plays a central role in biomarker discovery [1] . is includes the systematic screening of both patient samples and animal models of human diseases. Ideally diagnostic biomarkers are released or leaked from pathological tissues [2] and are therefore found at a su cient high concentration in body uids for convenient sampling by non-invasive or minimally invasive methods [3] . However, internal tissue-associated proteins also present a crucial source for general biomarker discovery [4] , including protein markers of neuromuscular disorders [5] .
is important aspect of comparative tissue proteomics as related to biomarker discovery is covered in this article, which focuses on muscle-associated proteins and the proteomic discovery of novel potential markers of muscular atrophy in primary motor neuronopathy. Over the last decade, muscle proteomics has been widely applied to studying myogenesis, bre adaptations, neuromuscular pathology and the natural aging process of contractile tissues [6] [7] [8] , using both total muscle protein extracts and distinct subcellular fractions [9] . Global proteomic data supports the idea that skeletal muscle bres are highly plastic cellular structures that can quickly adapt to changed functional demands [10] . However, if the neuromuscular system is not properly loaded due to prolonged inactivity, immobilization, lack of gravity or denervation, a relatively rapid process of muscular atrophy occurs [11] [12] [13] . Atrophying muscle bres are also observed as a consequence of sarcopenia of old age and certain neuromuscular pathologies.
e heterogeneous group of motor neuron diseases is a neurodegenerative disorder, which is characterized by a speci c form of muscular atrophy and progressive paralysis [14] . In this review, we compare the ndings from two recent studies that have analyzed the genetic wobbler (WR) mouse model of motor neuron disease by label-free mass spectrometry [15] versus uorescence two-dimensional di erence in-gel electrophoresis [16] . e systematic identi cation of muscular atrophy-related biomarker candidates by these two di erent large-scale separation and bioanalytical approaches is discussed with respect to sensitivity and coverage of proteins with di ering physicochemical properties.
Skeletal muscle diversity
Since the highly complex isoform expression pattern of the constituents of the actomyosin apparatus are severely altered during episodes of muscular atrophy, the main regulatory and contractile proteins are brie y introduced. e biophysical and metabolic diversity of contractile tissues, as well as the physiological adaptability of whole skeletal muscles to changed functional demands, is based on an extensive variability in contractile proteins and bioenergetic enzyme isoforms [17, 18] . In human muscles, the main ber types can be categorized as type I (slow), type IIA (fast) and type IID/X (fast), as well as a large number of hybrid bres. Distinct mixtures of bre types provide the contractile basis of the varying physiological demands of individual skeletal muscles [19] . e distribution of ber type-speci c myosins and metabolic enzymes is characteristic of fast-twitching bers with glycolytic metabolism, fast-twitching bers with an oxidative-glycolytic bioenergetics and slow-twitching bers with predominantly oxidative metabolism. e contractile apparatus contains a variety of contractile and regulatory protein families with numerous isoforms, which have been extensively studied by proteomics [20] . Actomyosinassociated proteins can be classi ed by their attachment to the thick laments located in the A-band and the thin laments in the I-band and overlapping A-band region of sarcomeres [21] . Myosin heavy chains, which head structures are involved in the molecular coupling between myosin laments and actin via cross-bridge/swinging-lever-arm mechanisms, represent the principal molecules of the thick lament [22] [23] [24] . Besides these main motor molecules, the regulatory and essential myosin light chains are engaged in the movement of phosphorylated myosin cross-bridges away from thick lament structures and the ne tuning of myosin motor function [25] . e actin lament-associated tropomyosin molecule plays a key inhibitory role in the regulation of actomyosin interactions [26] and the troponin complex provides the Ca 2+ -dependent regulatory adjustment of the contractile status [27] . e troponin TnC subunit represents the central Ca 2+ -sensor of the contractile apparatus and regulates actomyosin coupling, while the troponin TnT subunit is essential for the linkage between the inhibitory tropomyosin molecule and the troponin complex, and the troponin TnI subunit provides binding between the troponin complex and actin thereby mediating inhibition of actomyosin ATPase activity [28] . Besides myosins, actins, troponins and tropomyosins, a very large number of auxiliary proteins are present in the sarcomere structure [20] , including the important class of myosin binding proteins [29] . Myosin-binding protein MBP-C is located to the thick myosin laments and was shown to play a role in the maintenance and continuous stabilization of myosin-containing laments [30] . Its additional function involves the modulation of cross-bridge formation between myosin and actin molecules within the complex lamentous system of contractile bres [31] , as demonstrated by electron tomography of the physical mechanism that modulates the relative sliding between thick and thin laments [32] . Besides the isoform speci c distribution of contractile proteins, the distribution of metabolic enzymes is strikingly di erent between predominantly slow versus fast-twitching muscles [33] . During muscle adaptations or pathological changes in the neuromuscular system, the density and/or isoform expression patterns of proteins associated with the glycolytic pathway [34] and oxidative metabolism in mitochondria [35] are majorly altered. ese changes in bioenergetic enzyme pro les can be conveniently assayed by mass spectrometry-based proteomics and used to determine compensatory or disease-related shi s between anaerobic and aerobic muscle metabolism.
Motor neuron disease

e heterogeneous group of neurodegenerative syndromes that encapsulates motor neuron diseases is associated with progressive paralysis and includes spastic paraplegia, spinobulbar muscular atrophy, hereditary spastic paralysis, primary lateral sclerosis and amyotrophic lateral sclerosis (ALS) [14] . Figure 1 gives an overview of muscle bre type shi ing due to physiological adaptations or pathological insults, including motor neuron disease and its association with muscular atrophy [36] . In general, enhanced neuromuscular activity results in fast-to-slow transitions, while neuromuscular unloading is usually characterized by slow-to-fast transformation processes. Prolonged muscle disuse, the lack of gravity, immobilization or prolonged bed rest triggers the establishment of a faster muscle phenotype. Nerve crush, experimental denervation or the e ect of natural muscle aging involves progressive muscular atrophy. However, motor neuron disease was shown not to be linked to a clear slow-to-fast transformation process, but is characterized by more complex proteome-wide changes as discussed below in detail. ALS represents the most common form of motor neuron disease [37] . e adult-onset loss of lower and upper motor neurons causes a highly progressive form of paralysis, which can be sporadic or of genetic origin [38] . Neurodegeneration -related muscular atrophy results in debilitating limb and bulbar muscle weakness, as well as respiratory insu ciency [39] . A very large number of mutated genes were shown to be involved in familial or sporadic forms of ALS [40] [41] [42] [43] , including SOD1, Alsin, SETX, SPG11, FUS/TLS, VAPB, ANG, TARDBP, FIG4, OPTN, VCP, UBQLN2, SigMAR1, PFN1, ERBB4, C9orf72, CHMP2B, DAO, DCTN1, SQSTM1, hnRNPA1, Erlin2, UNC13A, NEFH, PRPH, TAF15, GRN, EWSR1 and ATXN2 [44] . Although most transcriptomic analyses of motor neuron disease have focused on spinal cord preparations and shown changed patterns of lipid metabolism, in ammation, cell adhesion and the immune response [45] [46] [47] , recently alterations in early gene expression were analysed by microarray screening of the gastrocnemius muscle from the SOD1 mouse model of ALS [48] . Motor neuron disease appears to be a multisystem disorder with a defective muscle metabolism, which is linked to di erential gene activation levels in epithelial-mesenchymal transitions and the Wnt/PI3-K signaling pathways in pre-symptomatic skeletal muscle. e inhibition of cell death, the promotion of cell proliferation and the repair of atrophying bres seems to be impaired in the gastrocnemius muscle of SOD1-G93A transgenic mice. Importantly, neuromuscular impairments seem to precede motor neuron death at pre-symptomatic periods of motor neuron disease [48] . is agrees with the gene expression analysis of skeletal muscle biopsies from ALS patients that demonstrated severe alterations in mRNA levels of major muscle proteins. Drastically lower mRNA levels were described for the fast isoform of myosin binding protein MPB-C and actinin alpha-3, while the mRNAs encoding collagen, actin, myosin-8 and annexin were shown to be elevated [49] .
Wobbler mouse model of motor neuron disease
Since comprehensive biochemical studies and subcellular fractionation procedures usually require relatively large amounts of starting material and because patient biopsy samples are scarce and show considerable inter-individual variability, genetic animal models of human diseases are o en used to accumulate su cient tissue for detailed proteomic analyses [50] . In the case of ALS research, various rodent models of motor neuron disease are used for routine pathobiochemical studies and to evaluate new pharmacological approaches [51] . One of the most established mouse models of hereditary motor neuron disease with progressive denervation is the wobbler mutant (genotype wr/wr, phenotype WR) [52] . A recent review by Moser et al. [53] has focused on the research progress made utilizing this animal model of ALS for studying the molecular pathogenesis of motor neuron disease. e underlying genetic abnormality in the WR mouse has been shown to be a missense mutation in the ubiquitously expressed gene Vps54 [54] . e protein product of the a ected gene is the vesicular protein sorting factor VPS54 and the mutation causes a leucine-toglutamine replacement (L967Q) within the C-terminal domain of VPS54. e hydrophobic-to-hydrophilic amino acid exchange in the primary sequence of this crucial subunit of the hetero-trimeric Golgi-associated retrograde protein (GARP) complex results in the destabilization of its tertiary protein structure causing a reduction in the VPS54 protein Figure 1 . Overview of skeletal muscle plasticity and bre transitions due to physiological adaptations or pathological insults to the neuromuscular system. Motor neuron disease is characterized by progressive muscular atrophy and complex changes in the skeletal muscle proteome. [55, 56] . Despite the fact that the WR mutation has not yet been identi ed in humans su ering from motor neuron disease [57] , the progressive WR mouse pathology resembles many aspects of ALS [53] . e progressive neurodegenerative and neuroin ammatory processes in the WR mouse are associated with astrocyte overgrowth in the brain stem and spinal cord, hippocampal hyper-excitability, a reduced number of interneurons and muscular atrophy [58] [59] [60] . Various experimental drug treatments have been tested with the WR mouse [61] [62] [63] , emphasizing the international acceptance of this ALS model mimicking the major pathophysiological and histopathological aspects of motor neuron disease [53] .
Proteomics of muscular atrophy and motor neuron disease
Large-scale screening studies at the level of the genome, transcriptome, proteome and metabolome have been initiated to determine global changes in patient biopsy specimens and animal models of motor neuron disease [64, 65] . Besides studies on spinal muscular atrophy [66, 67] , a variety of proteomic investigations have focused on ALS biomarker discovery and the pathobiochemical consequences of progressive neurodegeneration on bio uid proteomes [68, 69] . Proteome-wide pro ling studies have included the comprehensive analysis of cerebrospinal uid, cervical spinal cord specimens, lumbar spinal cord preparations and skeletal muscles [70] [71] [72] [73] [74] [75] . e WR mouse model of ALS has been studied by proteomics, focusing on abnormal protein expression in skeletal muscle [15, 16] and defective spermatogenesis [76] .
Proteomic pro ling of muscular atrophy
Muscular atrophy is associated with a variety of changes in neuromuscular activity levels, such as immobilization, zero gravity, extended periods of bed rest, prolonged muscular disuse, natural aging and traumatic denervation. Skeletal muscle atrophy has a profound e ect on muscle bre type distribution with an overall tendency of a slow-to-fast transition process [13, 77] . In contrast, endurance exercise, hyperexcitability or chronic low-frequency stimulation of muscle triggers the opposite changes in bre type speci cation, i.e. fast-to-slow muscle transformation, as clearly con rmed by proteomics [7, [78] [79] [80] . e fact that di erent loading of the neuromuscular system is re ected by distinct changes in the isoform expression pattern of contractile proteins has long been established by gel electrophoretic methodology [81] and the biochemical complexity of this process has more recently been con rmed by proteomics [20] .
Proteome-wide changes during di erent degrees of muscular unloading were evaluated by a variety of experimental systems, including hind limb suspension, joint xationinduced immobilization, long-term bed rest or complete denervation via sciatic nerve transection [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] . e general tendency of atrophying muscle to undergo slow-to-fast transitions was con rmed by changes in the abundance of a variety of metabolic enzymes, such as lactate dehydrogenase, enolase, triosephosphate isomerase and isocitrate dehydrogenase, which was accompanied by considerable alterations in contractile, structural and stress proteins [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] . Alterations in contractile proteins included speci c isoforms of myosin heavy chains, myosin light chains, troponins and tropomyosin [89, 92, 94, 95] . Although individual studies have shown that the degree of muscular atrophy di ers considerably following denervation, immobilization or prolonged disuse [85] [86] [87] [88] and that transient alterations are initially associated with a massive decrease in contractile proteins [82] [83] [84] , at a more advanced stage of bre atrophy a metabolic oxidative-to-glycolytic shi is observed [89, [94] [95] [96] . Table 1 lists major changes in key protein families due to muscular atrophy following denervation, immobilization or prolonged disuse.
Gel electrophoresis-based analysis of atrophying muscle in motor neuron disease
During the early stages of establishing proteomics as a new discipline within the eld of protein biochemistry, gel electrophoretic methodology has been widely employed for the e cient separating of complex protein mixtures prior to ingel trypsinisation for the swi identi cation of proteins of interest [97] [98] [99] . Although the application of gel-free methods using advanced liquid chromatography coupled with tandem mass spectrometry is now extensively used in proteomic screening studies [100] , uorescence two-dimensional in-gel electrophoresis (DIGE) is still widely employed for analyzing urea-soluble muscle protein populations [101] . In muscle proteomics, a considerable proportion of proteins can be separated by routine high-resolution twodimensional gel electrophoresis, including myosins, actins, troponins, tropomyosins and various auxiliary proteins of the contractile apparatus, as well as mitochondrial proteins, glycolytic enzymes, molecular chaperones and cytoskeletal proteins [102] . Since two-dimensional gels usually do not represent integral membrane proteins and high-molecularmass proteins su ciently, large one-dimensional gradient gels can be used in a complementary way to separate very large proteins prior to on-membrane digestion and subsequent mass spectrometric identi cation [103] [104] [105] . e owchart in Figure 2 outlines the usage of uorescence 2D-DIGE versus label-free LC-MS/MS analysis for the screening of pathological muscle specimens. e routine veri cation of novel biomarker candidates of motor neuron disease by immunoblot analysis is shown, illustrating an equal distribution of the extracellular matrix protein laminin as a loading control, the drastic decrease of the fast MBP-C isoform of myosin binding protein and increase of mitochondrial prohibitin, as previously shown by proteomics of WR muscle [15, 16] .
2D-DIGE using uorescent Cy2, Cy3 or Cy5 dyes has been originally developed by Minden et al. [106] [107] [108] and is now an established and reliable biomarker discovery method in Analysis of total extracts from rat soleus muscle following hindlimb suspension
2D-DIGE, MALDIToF MS, IB Tail suspension triggered increases in various GLY enzymes, MYO, CA3 and ALB, and decreases in OXPHOS enzymes, ACT, TnT and a variety of MHCs and MLCs
Moriggi et al. [89] Subproteomic analysis of rat soleus muscle following hindlimb immobilization 1D-GE, MALDI-ToF MS, IB Focused study revealed preferential oxidization of CA3 and fourand-a-half LIM protein during muscle unloading Chen et al. [90] Analysis of proteolysis in rat gastrocnemius muscle following hindlimb suspension 2D-GE, CBB, MALDIToF/ToF MS, IB One week of muscle unloading was associated with coordinated and time-dependent activation of proteolysis of contractile proteins; increase in GLY enzymes Ferreira et al. [91] Subproteomic analysis of sarcoplasmic and myo brillar fractions from denervated rat soleus muscle
2D-GE, Flamingo gel stain, MALDI-ToF MS, IB
Denervation resulted in a decrease in slow MLC1 and an increase in fast MLC1; di erential e ects on HSPs, GLY and OXPHOS enzymes Sato et al. [92] Subproteomic analysis of membrane proteins from rat soleus muscle following hindlimb unloading Native Blue 2D-GE, silver staining, MALDI -ToF MS, IB
Complex changes including an increase in AS and the AQP4 water channel, as well as di erential e ects on dystrophin-glycoprotein complex Basco et al. [93] Analysis of total extracts from human vastus lateralis and soleus muscle following long-term bed rest
2D-DIGE, MALDIToF MS, LC-MS/MS, IB
Long-term disuse caused increased MHCI, GT, various HSPs, MYO and GLY enzymes, and decreased MHCIIA, ACT and OXPHOS enzymes Moriggi et al. [94] Analysis of total extracts from denervated rat tibialis anterior muscle iTRAQ labeling, LC-MS/MS, IB Labeling analysis revealed large numbers of di erential changes in metabolic enzymes, molecular chaperones and contractile proteins, including a decrease in many MHCs, MLCs, TM, TUB and OXPHOS enzymes, and increases in HSP70, HSP90, αBC and GT Sun et al. [95] Analysis of total extracts from denervated rat tibialis anterior muscle iTRAQ labeling, LC-MS/MS, IB Switch of α-isoform and β-isoform of ENO during slow-to-fast transitions, as well as di erential changes of OXPHOS enzymes Sun et al. [96] skeletal muscle pathology [109] . Fluorescent 2-CyDye or 3-CyDye systems are used to establish di erential and preelectrophoretic tagging of more than one proteome, thereby decisively reducing gel-to-gel variations during comparative protein separation [110] . In conjunction with optimized 2D so ware analysis tools [111] , the advanced DIGE technique represents an unparalleled analytical tool for the establishment of distinct di erences in protein expression patterns between normal and diseased tissue specimens [112] . Changes in skeletal muscles from the SOD mouse [75] and the WR mouse [16] model of motor neuron disease have been recently studied by 2D-DIGE analysis. Table 2 lists key ndings from these proteomic studies of motor neuron disease and Figure 3A shows graphically the identi ed protein species with a di ering abundance in atrophying WR muscle. Characteristic signs of denervation have previously been shown to Gel electrophoresis and immunoblot analysis was carried out as previously described in detail [15, 16] . Table 2 . Proteomic pro ling of motor neuron disease. Listed are recent studies that have used mass spectrometry-based proteomics to investigate muscular atrophy due to motor neuron disease.
Abbreviations used: αBC, alphaB-crystallin; ACT, actin; ALB, albumin; AS, ATP synthase; CK, creatine kinase; DES, desmin; DIGE, di erence in-gel electrophoresis; GLY, glycolytic enzymes; HSP, heat shock protein; LC, liquid chromatography; MBP, myosin binding protein; MLC, myosin light chain; MS, mass spectrometry; MYO, myoglobin; OXPHOS, enzymes of oxidative phosphorylation; TnC, TnI, TnT; troponin subunits; TUB, tubulin; SERCA, sarcoplasmic or endoplasmic reticulum calcium ATPase.
Proteomic study Methods Changed proteins References
Analysis of total extracts from hindlimb muscle of wobbler mouse model of motor neuron disease
2D-DIGE, LC-MS/ MS, IB
Disease-associated muscular atrophy with preferential e ects on speci c synapse types is associated with a drastic decrease in fast MBP-C, as well as increases in MLC1, ACT, TnC, GLY enzymes, MYO, CK and DES Staunton et al. [16] Analysis of total extracts from hindlimb muscle of SOD mouse model of motor neuron disease
2D-DIGE, MALDIToF MS, LC-MS/MS, IB
Disease-associated muscular atrophy with preferential e ects on speci c synapse types is associated with complex changes in proteins involved in metabolism, contraction and cellular stress response, such as GLY enzymes, OXPHOS enzymes, TUB, HSP90 and αBC Capitanio et al. [75] Analysis of total extracts from hindlimb muscle of wobbler mouse model of motor neuron disease Label-free MS analysis, IB Disease-associated muscular atrophy with preferential e ects on speci c synapse types is associated with drastic decreases in fast MBP-C, titin and SERCA1, and increases in DES, various HSPs, AS, ALB, MLC1/3, TnI, TnC and TnT
Holland et al. [15] Figure 3. Comparison of proteomic markers of motor neuron disease as determined by uorescence di erence in-gel electrophoresis (DIGE) (A) versus label-free mass spectrometric (MS) analysis (B, C) using skeletal muscle from the wobbler (WR) mouse model [15, 16] . e fold-change of individual muscle proteins is graphically presented and clearly shows that the application of label-free mass spectrometry has resulted in a larger number of identi ed protein species with a wider range of concentration changes as compared to gel-based proteomics.
occur in WR skeletal muscles, including an increase of mRNA levels encoding the principal α-subunit of the nicotinic acetylcholine receptor at the junctional folds [113] and a drastic shi to a high proportion of the fast-glycolytic MHCIIB isoform of myosin heavy chain [81] . However, the DIGE analysis of the WR muscle proteome has demonstrated that global changes in motor neuron disease are highly complex [16] and di er from the mostly unilateral shi s in isoform expression patterns observed following experimental denervation or prolonged muscle disuse [89, 92, 94] . Increased expression levels in WR muscle were shown for the glycolytic enzymes aldolase and glyceraldehyde 3-phosphate dehydrogenase, the contractile and cytoskeletal proteins actin, desmin, myozenin, troponin TnC, actinin and fast myosin light chain MLC1f, as well as myoglobin [16] . e M-type isoform of creatine kinase exhibited di erential changes in a variety of 2D spots, which suggested the presence of di erently phosphorylated isoforms following gel electrophoretic separation. An interesting nding was the elevated level of Cu/Zn superoxide dismutase, an enzyme of crucial importance for the antioxidant defence of skeletal muscle bres, which is intrinsically involved in various forms of ALS [114] . As illustrated in the immunoblot analysis of Figure 2 , the abundance of the mostly cytosolic SOD1 isoform and the mitochondrial SOD2 isoform of superoxide dismutase is di erently a ected in WR skeletal muscle. e 2D-DIGE analysis of the WR model also revealed the drastic reduction in the density of protein spots representing the fast isoform of myosin binding protein MBP-C [16] , which has been clearly con rmed by immunoblotting (Figure 2) .
is makes the muscular atrophy-related modulations in MBP-C, in conjunction with concentration changes in myosin light chains, myosin heavy chains, actin, troponin, actinin and myozenin, an interesting nding and suggests MBP-C as a novel muscle-associated biomarker candidate of motor neuron disease. Interestingly, the cardiac equivalent of this regulatory protein of the contractile apparatus, cMBP -C [115] , was shown to be cleaved during ischemic injury to the heart in a phosphorylation-dependent manner [116] and the release of an N-terminal fragment into the circulation may be useful as a new biomarker of diagnosing myocardial infarction [117] .
Label-free mass spectrometric analysis of atrophying muscle in motor neuron disease
In contrast to gel-based methods, liquid chromatography in combination with advanced mass spectrometry can routinely identify low copy numbers of integral membrane proteins, high-molecular mass proteins and components with extreme isoelectric points and/or post-translational modications. Figure 2 shows the comparison of total numbers of identi ed proteins using label-free MS analysis versus the DIGE method. While the uorescence 2D-DIGE analysis identi ed 21 decreased protein spots and 3 decreased protein spots in WR muscle samples [16] , the label-free mass spectrometric analysis of the same tissue preparations revealed 63 increased proteins and 9 decreased proteins in mutant muscle, including integral membrane proteins such as the Ca 2+ -ATPase of the sarcoplasmic reticulum [15] . e mass spectrometric identi cation of the SERCA1 isoform of the luminal Ca 2+ -pump demonstrates the advantageous and complementary nature of the gel-free LC-MS/MS method for detecting changes in a highly hydrophobic muscle protein. e considerably larger number of proteins identi ed by label-free mass spectrometry is graphically presented in Figure 3B ,C. In analogy to the ndings from 2D-DIGE studies of motor neuron disease [16, 75] , label-free LC-MS/MS analysis con rmed the pathobiochemical complexity of changes in the WR muscle proteome due to progressive neurodegeneration [15] . Proteome-wide alterations included components associated with energy metabolism, metabolite transportation, muscle contraction, ion homeostasis, structural integrity and the cellular stress response [15] .
A bioinformatic STRING analysis of the proteomic data from the label-free mass spectrometric analysis of WR leg muscle was carried out [15] . In order to determine potential protein-protein interactions of the mass spectrometrically identi ed proteins with an altered concentration in atrophying WR muscle, the publically available STRING (http:// string-db.org/; version 9.1) database was used, which contains known and predicted protein interactions including direct physical and indirect functional protein associations [118] . e resulting interaction map revealed how complex the protein interactions patterns are between the a ected protein species in WR muscle (not shown). is is especially striking with respect to interaction nodes containing contractile elements, cytoskeletal proteins, metabolic enzymes and molecular chaperones. A signi cantly increased abundance was shown for myosin light chains, the troponin subunits TnI, TnC and TnT, and the regulatory element tropomyosin, as well as aldehyde dehydrogenase, histone protein H4, the nuclear envelope protein lamin, fatty acid binding protein, fructose-1,6-bisphosphatase, four-and-a-half LIM domains protein 1, carbonic anhydrase CA3 and annexin. Higher levels of heat shock protein beta-1, peptidyl-prolyl cis -trans isomerase A and the small heat shock protein αB-crystallin suggested an elevated cellular stress response in WR muscle [15] . e previous immunoblot analysis of essential Ca 2+ -binding proteins demonstrated that the luminal Ca 2+ -shuttling protein sarcalumenin of the longitudinal tubules and the highly abundant Ca 2+ -bu ering protein calsequestrin of the terminal cisternae are increased in WR muscle [15] . In contrast, the cytosolic Ca 2+ -binding protein parvalbumin is decreased in atrophying bres [15, 16] . ese complex proteome-wide alterations suggest that distinct di erences exist between disease-related muscular atrophy and the above outlined changes due to muscular disuse or experimental denervation. Di erential changes in proteins associated with glycolytic or oxidative mitochondrial metabolism indicate that WR muscle does not undergo a unidirectional transition towards a particular bioenergetic pheno-type. In motor neuron disease, the metabolic weighting of bioenergetic pathways and fibre type specification appears to be influenced by at least two main mechanisms. Firstly, a differing degree of a subtype-specific vulnerability of neuromuscular synapses and secondarily, highly complex patterns of compensatory mechanisms of fibre type shifting. Thus, in contrast to an overall slow-to-fast transformation process during muscular disuse or denervation, motor neuron disease seems to be related to changes in both slow and fast isoforms of muscle marker proteins.
Concluding Remarks
Pathobiochemical insights from label-free mass spectrometry and fluorescence 2D-DIGE analysis are of considerable interest to the field of muscle pathology, but are also crucial for furthering the discovery of specific protein biomarkers of ALS. Figure 4 summaries the main groups of muscle-associated proteins changed in the WR model of motor neuron disease as recently determined by proteomics. Interesting new findings are the identification of increased levels of certain mitochondrial proteins, suggesting that muscular atrophy in WR muscle is not directly linked to slow-to-fast fibre type shifting, but probably initially involves a preferential loss of neuromuscular synapses that function under normal conditions within a fast type of innervation process. The increased concentration of a variety of heat shock proteins agrees with the idea of extensive cellular stress in ALS and the continuous requirement to remove or re-fold large numbers of affected proteins. A promising new muscleassociated biomarker of motor neuron disease is the fast isoform of MBP-C. A decrease in this major auxiliary protein of the contractile apparatus was demonstrated by the fluorescence 2D-DIGE technique [16] , LC-MS/MS analysis [15] and the transcriptomic screening of ALS muscle biopsies [49] , making this filament-associated component a suitable biomarker candidate of ALS. The future screening of large numbers of ALS patient samples will be needed to fully establish the newly identified proteomic markers as reliable indicators of disease-related muscular atrophy [119] . Hopefully a few of these proteins will be exploitable to design superior prognostic and therapy monitoring assay systems consisting of a meaningful and diagnostically conclusive biomarker signature. In the future, it can be expected that biomarkers of ALS will play a prominent role for a more accurate diagnosis, the proper monitoring of muscular atrophy and the determination of clinical outcome measures. Listed are subcellular regions, metabolic pathways, cellular processes and protein families that are majorly altered in skeletal muscles due to progressive neurodegeneration. Various newly identi ed muscle-associated proteins with a changed abundance may be useful as novel biomarker candidates for the design of improved diagnostic, prognostic or therapy monitoring assay systems.
